waypoint wealth counsel decreased its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 14.6% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,400 shares of the company’s stock after selling 239 shares during the quarter. waypoint wealth counsel’s holdings in Procter & Gamble were worth $223,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also recently made changes to their positions in PG. Kingstone Capital Partners Texas LLC grew its holdings in shares of Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after buying an additional 76,017,350 shares during the last quarter. Nuveen LLC purchased a new stake in Procter & Gamble in the first quarter worth approximately $1,954,941,000. Price T Rowe Associates Inc. MD boosted its holdings in Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares during the last quarter. Invesco Ltd. boosted its holdings in Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares during the last quarter. Finally, Valeo Financial Advisors LLC boosted its holdings in Procter & Gamble by 1,875.5% in the second quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock worth $280,946,000 after purchasing an additional 1,674,139 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Procter & Gamble Trading Down 0.6%
Shares of Procter & Gamble stock opened at $149.69 on Monday. The company’s fifty day simple moving average is $155.24 and its 200-day simple moving average is $159.41. The stock has a market capitalization of $350.34 billion, a PE ratio of 22.99, a P/E/G ratio of 3.97 and a beta of 0.36. Procter & Gamble Company has a 1-year low of $149.45 and a 1-year high of $180.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.
Insider Activity at Procter & Gamble
In related news, insider Marc S. Pritchard sold 9,849 shares of Procter & Gamble stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the transaction, the insider owned 182,422 shares in the company, valued at approximately $28,689,507.94. The trade was a 5.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Shailesh Jejurikar sold 13,039 shares of Procter & Gamble stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the transaction, the chief operating officer owned 28,036 shares in the company, valued at approximately $4,409,221.72. This trade represents a 31.74% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 149,763 shares of company stock worth $23,421,279 in the last 90 days. Company insiders own 0.20% of the company’s stock.
Analysts Set New Price Targets
Several equities research analysts recently issued reports on the stock. Weiss Ratings restated a “hold (c+)” rating on shares of Procter & Gamble in a report on Wednesday, October 8th. BNP Paribas Exane dropped their target price on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a report on Tuesday, September 23rd. Berenberg Bank raised their target price on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a report on Wednesday, September 17th. UBS Group dropped their target price on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, Wells Fargo & Company dropped their target price on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a report on Thursday, September 25th. Eleven equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $172.21.
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- High Flyers: 3 Natural Gas Stocks for March 2022
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Could Target’s Week of Discounts Come Full Circle for Investors?
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.